{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T13:08:09Z","timestamp":1790082489913,"version":"4.0.1"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T00:00:00Z","timestamp":1759968000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001774","name":"The University of Sydney","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Colorectal Dis"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Purpose<\/jats:title>\n            <jats:p>To report (1) efficacy and (2) safety outcomes comparing extended thromboprophylaxis (ETP) with low molecular weight heparin (LMWH) and direct oral anticoagulants (DOAC) versus no ETP after colorectal surgery.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>A systematic review using MEDLINE, EMBASE and Cochrane Central Register of Controlled Trials to March 2024. Randomised controlled trials and observational studies investigating ETP with LMWH or DOAC for at least 28\u00a0days were included. (1) Efficacy outcome was venous thromboembolism (VTE) rate at 30-days postoperatively. (2) Safety outcomes included major bleeding events at 30\u201390-days. Odds ratio (OR) and 95% confidence intervals (CI) were calculated using a Mantel\u2013Haenszel fixed effects model.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Five studies (2936 patients) investigating colorectal surgery for colorectal cancer (CRC) or inflammatory bowel disease (IBD) were included. Total VTE rates were significantly reduced in the LMWH ETP group compared with no ETP [0.56% (OR 0.18, 95% CI 0.07\u20130.50]. The DOAC ETP group was also compared with no ETP with lower total VTE rates [OR 0.22, 95% CI 0.08\u20130.67]. There was no difference in VTE rates between LMWH and DOAC ETP. There were no differences in major bleeding events in the LMWH ETP group at 90-days [OR 0.25, 95% CI 0.03\u20132.24], or the DOAC ETP at 30-days [OR 2.68, 95% CI 0.32\u201322.35]. There were no VTE-related mortalities at 90-days in either group.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>ETP after colorectal surgery for CRC and IBD reduced the incidence of VTEs with no impact on major bleeding within 90-days. ETP for at least 28\u00a0days should be considered particularly for those who have a high risk for postoperative VTE.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00384-025-05002-9","type":"journal-article","created":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T04:21:26Z","timestamp":1759983686000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The efficacy and safety of extended thromboprophylaxis after colorectal surgery: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"40","author":[{"given":"Joseph Do Woong","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nguyen","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Talia","family":"Shepherd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aswin","family":"Shanmugalingam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona Lee","family":"Gavegan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Shedden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nimalan","family":"Pathmanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toufic","family":"El-Khoury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry","family":"Hitos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Wei Tatt","family":"Toh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,9]]},"reference":[{"issue":"2","key":"5002_CR1","doi-asserted-by":"publisher","first-page":"e2354352","DOI":"10.1001\/jamanetworkopen.2023.54352","volume":"7","author":"J Bj\u00f6rklund","year":"2024","unstructured":"Bj\u00f6rklund J, Rautiola J, Zelic R, Edgren G, Bottai M, Nilsson M et al (2024) Risk of venous thromboembolic events after surgery for cancer. JAMA Netw Open 7(2):e2354352\u2013e","journal-title":"JAMA Netw Open"},{"issue":"1","key":"5002_CR2","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1001\/jamasurg.2013.3172","volume":"149","author":"VQ Trinh","year":"2014","unstructured":"Trinh VQ, Karakiewicz PI, Sammon J, Sun M, Sukumar S, Gervais MK et al (2014) Venous thromboembolism after major cancer surgery: temporal trends and patterns of care. JAMA Surg 149(1):43\u20139","journal-title":"JAMA Surg"},{"key":"5002_CR3","first-page":"165","volume":"14","author":"K Alizadeh","year":"2005","unstructured":"Alizadeh K, Hyman N (2005) Venous thromboembolism prophylaxis in colorectal surgery. Surg Technol Int 14:165\u201370","journal-title":"Surg Technol Int"},{"issue":"1","key":"5002_CR4","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1097\/01.sla.0000193959.44677.48","volume":"243","author":"G Agnelli","year":"2006","unstructured":"Agnelli G, Bolis G, Capussotti L, Scarpa RM, Tonelli F, Bonizzoni E et al (2006) A clinical outcome-based prospective study on venous thromboembolism after cancer surgery: the @RISTOS project. Ann Surg 243(1):89\u201395","journal-title":"Ann Surg"},{"issue":"3","key":"5002_CR5","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1097\/DCR.0000000000001036","volume":"61","author":"F Ali","year":"2018","unstructured":"Ali F, Al-Kindi SG, Blank JJ, Peterson CY, Ludwig KA, Ridolfi TJ (2018) Elevated venous thromboembolism risk following colectomy for IBD is equal to those for colorectal cancer for ninety days after surgery. Dis Colon Rectum 61(3):375\u201381","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"5002_CR6","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1111\/j.1538-7836.2010.03892.x","volume":"8","author":"VV Kakkar","year":"2010","unstructured":"Kakkar VV, Balibrea JL, Mart\u00ednez-Gonz\u00e1lez J, Prandoni P (2010) Extended prophylaxis with bemiparin for the prevention of venous thromboembolism after abdominal or pelvic surgery for cancer: the CANBESURE randomized study. J Thromb Haemost 8(6):1223\u20139","journal-title":"J Thromb Haemost"},{"issue":"6 Suppl","key":"5002_CR7","doi-asserted-by":"publisher","first-page":"381s","DOI":"10.1378\/chest.08-0656","volume":"133","author":"WH Geerts","year":"2008","unstructured":"Geerts WH, Bergqvist D, Pineo GF, Heit JA, Samama CM, Lassen MR et al (2008) Prevention of venous thromboembolism: American college of chest physicians evidence-based clinical practice guidelines (8th edition). Chest 133(6 Suppl):381s\u2013453s","journal-title":"Chest"},{"issue":"12","key":"5002_CR8","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.3748\/wjg.v26.i12.1231","volume":"26","author":"K Cheng","year":"2020","unstructured":"Cheng K, Faye AS (2020) Venous thromboembolism in inflammatory bowel disease. World J Gastroenterol 26(12):1231\u201341","journal-title":"World J Gastroenterol"},{"issue":"9","key":"5002_CR9","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1111\/j.1445-2197.2012.06245.x","volume":"83","author":"P Smart","year":"2013","unstructured":"Smart P, Burbury K, Lingaratnam S, Lynch AC, Mackay J, Heriot A (2013) Thromboprophylaxis among Australasian colorectal surgeons. ANZ J Surg 83(9):646\u201350","journal-title":"ANZ J Surg"},{"issue":"12","key":"5002_CR10","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1007\/s11605-014-2647-5","volume":"18","author":"Z Moghadamyeghaneh","year":"2014","unstructured":"Moghadamyeghaneh Z, Hanna MH, Carmichael JC, Nguyen NT, Stamos MJ (2014) A nationwide analysis of postoperative deep vein thrombosis and pulmonary embolism in colon and rectal surgery. J Gastrointest Surg 18(12):2169\u201377","journal-title":"J Gastrointest Surg"},{"issue":"1","key":"5002_CR11","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1016\/j.thromres.2012.10.014","volume":"131","author":"TH Toledano","year":"2013","unstructured":"Toledano TH, Kondal D, Kahn SR, Tagalakis V (2013) The occurrence of venous thromboembolism in cancer patients following major surgery. Thromb Res 131(1):e1\u20135","journal-title":"Thromb Res"},{"issue":"4","key":"5002_CR12","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1097\/SLA.0000000000000340","volume":"259","author":"MC Vedovati","year":"2014","unstructured":"Vedovati MC, Becattini C, Rondelli F, Boncompagni M, Camporese G, Balzarotti R et al (2014) A randomized study on 1-week versus 4-week prophylaxis for venous thromboembolism after laparoscopic surgery for colorectal cancer. Ann Surg 259(4):665\u20139","journal-title":"Ann Surg"},{"issue":"8","key":"5002_CR13","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1182\/blood.2022015796","volume":"140","author":"C Becattini","year":"2022","unstructured":"Becattini C, Pace U, Pirozzi F, Donini A, Avruscio G, Rondelli F et al (2022) Rivaroxaban vs placebo for extended antithrombotic prophylaxis after laparoscopic surgery for colorectal cancer. Blood 140(8):900\u20138","journal-title":"Blood"},{"key":"5002_CR14","doi-asserted-by":"crossref","unstructured":"Felder S, Rasmussen MS, King R, Sklow B, Kwaan M, Madoff R et al (2019) Prolonged thromboprophylaxis with low molecular weight heparin for abdominal or pelvic surgery. Cochrane Database Syst Rev 3(3):Cd004318","DOI":"10.1002\/14651858.CD004318.pub5"},{"key":"5002_CR15","unstructured":"National Institute for Health and Care Excellence: Guidelines. Venous thromboembolism in over 16s: reducing the risk of hospital-acquired deep vein thrombosis or pulmonary embolism. London: National Institute for Health and Care Excellence (NICE)\u00a0Copyright \u00a9 NICE 2018"},{"issue":"2 Suppl","key":"5002_CR16","doi-asserted-by":"publisher","first-page":"e419S","DOI":"10.1378\/chest.11-2301","volume":"141","author":"C Kearon","year":"2012","unstructured":"Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ (2012) Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians evidence-based clinical practice guidelines. Chest 141(2 Suppl):e419S\u2013e96S","journal-title":"Chest"},{"issue":"3","key":"5002_CR17","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/j.amjsurg.2018.11.046","volume":"218","author":"M Carrier","year":"2019","unstructured":"Carrier M, Altman AD, Blais N, Diamantouros A, McLeod D, Moodley U (2019) Extended thromboprophylaxis with low-molecular weight heparin (LMWH) following abdominopelvic cancer surgery. Am J Surg 218(3):537\u201350","journal-title":"Am J Surg"},{"issue":"9","key":"5002_CR18","doi-asserted-by":"publisher","first-page":"1162","DOI":"10.1097\/DCR.0000000000002975","volume":"66","author":"SV Patel","year":"2023","unstructured":"Patel SV, Liberman SA, Burgess PL, Goldberg JE, Poylin VY, Messick CA (2023) The American Society of Colon and Rectal Surgeons clinical practice guidelines for the reduction of venous thromboembolic disease in colorectal surgery. Dis Colon Rectum 66(9):1162\u201373","journal-title":"Dis Colon Rectum"},{"issue":"6","key":"5002_CR19","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.7410","volume":"3","author":"SR Guntupalli","year":"2020","unstructured":"Guntupalli SR, Brennecke A, Behbakht K, Tayebnejad A, Breed CA, Babayan LM et al (2020) Safety and efficacy of apixaban vs enoxaparin for preventing postoperative venous thromboembolism in women undergoing surgery for gynecologic malignant neoplasm: a randomized clinical trial. JAMA Netw Open 3(6):e207410","journal-title":"JAMA Netw Open"},{"key":"5002_CR20","doi-asserted-by":"publisher","DOI":"10.1177\/10760296221132556","volume":"28","author":"ALM de Longo Oliveira","year":"2022","unstructured":"de Longo Oliveira ALM, de Oliveira Pereira RF, Agati LB, Ribeiro CM, Kawamura Suguiura GY, Cioni CH et al (2022) Rivaroxaban versus enoxaparin for thromboprophylaxis after major gynecological cancer surgery: the VALERIA trial\u202f: venous thromboembolism prophylaxis after gynecological pelvic cancer surgery with rivaroxaban versus enoxaparin (VALERIA trial). Clin Appl Thromb Hemost 28:10760296221132556","journal-title":"Clin Appl Thromb Hemost"},{"issue":"8","key":"5002_CR21","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1002\/ajh.26945","volume":"98","author":"M Zhao","year":"2023","unstructured":"Zhao M, Bao Y, Jiang C, Chen L, Xu L, Liu X et al (2023) Rivaroxaban versus nadroparin for thromboprophylaxis following thoracic surgery for lung cancer: a randomized, noninferiority trial. Am J Hematol 98(8):1185\u201395","journal-title":"Am J Hematol"},{"issue":"2","key":"5002_CR22","doi-asserted-by":"publisher","first-page":"476","DOI":"10.1016\/j.ygyno.2020.07.096","volume":"159","author":"A Glickman","year":"2020","unstructured":"Glickman A, Brennecke A, Tayebnejad A, Matsuo K, Guntupalli SR, Sheeder J (2020) Cost-effectiveness of apixaban for prevention of venous thromboembolic events in patients after gynecologic cancer surgery. Gynecol Oncol 159(2):476\u201382","journal-title":"Gynecol Oncol"},{"key":"5002_CR23","doi-asserted-by":"crossref","unstructured":"Najjar PA, Madenci AL, MeInitchouk N, Irani J, Goldberg J, Bleday R. P362 Impact of a Post-Discharge Venous Thromboembolism (VTE) Prophylaxis program in patients undergoing surgery for colorectal cancer or inflammatory bowel disease (IBD). The American Society of Colon and Rectal Surgeon\u2019s Annual Meeting Abstracts. Diseases of the Colon & Rectum. 2018;61(5):e38\u2013e333.","DOI":"10.1097\/DCR.0000000000001104"},{"key":"5002_CR24","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2022-071375","volume":"378","author":"RC Auer","year":"2022","unstructured":"Auer RC, Ott M, Karanicolas P, Brackstone MR, Ashamalla S, Weaver J et al (2022) Efficacy and safety of extended duration to perioperative thromboprophylaxis with low molecular weight heparin on disease-free survival after surgical resection of colorectal cancer (PERIOP-01): multicentre, open label, randomised controlled trial. BMJ 378:e071375","journal-title":"BMJ"},{"issue":"3","key":"5002_CR25","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1097\/DCR.0000000000003107","volume":"67","author":"JW Ogilvie Jr.","year":"2024","unstructured":"Ogilvie JW Jr., Khan MT, Hayakawa E, Parker J, Luchtefeld MA (2024) Low-dose rivaroxaban as extended prophylaxis reduces postdischarge venous thromboembolism in patients with malignancy and IBD. Dis Colon Rectum 67(3):457\u201365","journal-title":"Dis Colon Rectum"},{"issue":"13","key":"5002_CR26","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1056\/NEJMoa012385","volume":"346","author":"D Bergqvist","year":"2002","unstructured":"Bergqvist D, Agnelli G, Cohen AT, Eldor A, Nilsson PE, Le Moigne-Amrani A et al (2002) Duration of prophylaxis against venous thromboembolism with enoxaparin after surgery for cancer. N Engl J Med 346(13):975\u201380","journal-title":"N Engl J Med"},{"issue":"5","key":"5002_CR27","doi-asserted-by":"publisher","first-page":"1422","DOI":"10.1245\/s10434-016-5127-1","volume":"23","author":"A Fagarasanu","year":"2016","unstructured":"Fagarasanu A, Alotaibi GS, Hrimiuc R, Lee AY, Wu C (2016) Role of extended thromboprophylaxis after abdominal and pelvic surgery in cancer patients: a systematic review and meta-analysis. Ann Surg Oncol 23(5):1422\u201330","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"5002_CR28","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000024479","volume":"100","author":"X Lu","year":"2021","unstructured":"Lu X, Zeng W, Zhu L, Liu L, Du F, Yang Q (2021) Application of the Caprini risk assessment model for deep vein thrombosis among patients undergoing laparoscopic surgery for colorectal cancer. Medicine (Baltimore) 100(4):e24479","journal-title":"Medicine (Baltimore)"},{"key":"5002_CR29","doi-asserted-by":"publisher","first-page":"107602962110737","DOI":"10.1177\/10760296211073748","volume":"28","author":"J Yao","year":"2022","unstructured":"Yao J, Lang Y, Su H, Dai S, Ying K (2022) Construction of risk assessment model for venous thromboembolism after colorectal cancer surgery: a Chinese single-center study. Clin Appl Thromb Hemost 28:10760296211073748","journal-title":"Clin Appl Thromb Hemost"},{"issue":"1","key":"5002_CR30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/j.jvsv.2019.06.015","volume":"8","author":"K Lobastov","year":"2020","unstructured":"Lobastov K, Dementieva G, Soshitova N, Bargandzhiya A, Barinov V, Laberko L et al (2020) Utilization of the Caprini score in conjunction with thrombodynamic testing reduces the number of unpredicted postoperative venous thromboembolism events in patients with colorectal cancer. J Vasc Surg Venous Lymphat Disord 8(1):31\u201341","journal-title":"J Vasc Surg Venous Lymphat Disord"},{"issue":"8","key":"5002_CR31","doi-asserted-by":"publisher","first-page":"801","DOI":"10.5551\/jat.51359","volume":"27","author":"H Bo","year":"2020","unstructured":"Bo H, Li Y, Liu G, Ma Y, Li Z, Cao J et al (2020) Assessing the risk for development of deep vein thrombosis among Chinese patients using the 2010 Caprini risk assessment model: a prospective multicenter study. J Atheroscler Thromb 27(8):801\u20138","journal-title":"J Atheroscler Thromb"},{"issue":"11","key":"5002_CR32","doi-asserted-by":"publisher","DOI":"10.1016\/j.cpsurg.2022.101221","volume":"59","author":"S Wilson","year":"2022","unstructured":"Wilson S, Chen X, Cronin M, Dengler N, Enker P, Krauss ES et al (2022) Thrombosis prophylaxis in surgical patients using the Caprini risk score. Curr Probl Surg 59(11):101221","journal-title":"Curr Probl Surg"},{"issue":"2","key":"5002_CR33","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1160\/TH04-09-0570","volume":"93","author":"P Wille-J\u00f8rgensen","year":"2005","unstructured":"Wille-J\u00f8rgensen P, Jorgensen LN, Crawford M (2005) Asymptomatic postoperative deep vein thrombosis and the development of postthrombotic syndrome. A systematic review and meta-analysis. Thromb Haemost 93(2):236\u201341","journal-title":"Thromb Haemost"},{"issue":"1","key":"5002_CR34","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1160\/TH04-05-0323","volume":"93","author":"PT Vaitkus","year":"2005","unstructured":"Vaitkus PT, Leizorovicz A, Cohen AT, Turpie AG, Olsson CG, Goldhaber SZ (2005) Mortality rates and risk factors for asymptomatic deep vein thrombosis in medical patients. Thromb Haemost 93(1):76\u20139","journal-title":"Thromb Haemost"},{"issue":"5","key":"5002_CR35","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1046\/j.1538-7836.2003.00111.x","volume":"1","author":"H Arnesen","year":"2003","unstructured":"Arnesen H, Dahl OE, Aspelin T, Seljeflot I, Kierulf P, Lyberg T (2003) Sustained prothrombotic profile after hip replacement surgery: the influence of prolonged prophylaxis with dalteparin. J Thromb Haemost 1(5):971\u20135","journal-title":"J Thromb Haemost"},{"issue":"9275","key":"5002_CR36","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/S0140-6736(00)05249-1","volume":"358","author":"JW Eikelboom","year":"2001","unstructured":"Eikelboom JW, Quinlan DJ, Douketis JD (2001) Extended-duration prophylaxis against venous thromboembolism after total hip or knee replacement: a meta-analysis of the randomised trials. Lancet 358(9275):9\u201315","journal-title":"Lancet"},{"issue":"10","key":"5002_CR37","doi-asserted-by":"publisher","first-page":"858","DOI":"10.7326\/0003-4819-135-10-200111200-00006","volume":"135","author":"RD Hull","year":"2001","unstructured":"Hull RD, Pineo GF, Stein PD, Mah AF, MacIsaac SM, Dahl OE et al (2001) Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review. Ann Intern Med 135(10):858\u201369","journal-title":"Ann Intern Med"}],"container-title":["International Journal of Colorectal Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-025-05002-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00384-025-05002-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00384-025-05002-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T04:21:29Z","timestamp":1759983689000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00384-025-05002-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,9]]},"references-count":37,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5002"],"URL":"https:\/\/doi.org\/10.1007\/s00384-025-05002-9","relation":{},"ISSN":["1432-1262"],"issn-type":[{"value":"1432-1262","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,9]]},"assertion":[{"value":"10 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 September 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"211"}}